Skip to main content

Rescentris, Genedata, caBIG, Computational Biology PhD

Premium

US Air Force Labs Licenses Rescentris' Electronic Lab Notebook

The Cellular Dynamics and Engineering Program at Wright-Patterson Air Force Base has deployed Rescentris' electronic lab notebook product, Columbus, the company said last week.

Rescentris' Collaborative Electronic Research Framework (CERF) "is a candidate for being a Department of Defense standard piece of software for life sciences research efforts," Chris Geib, a contracted information technology manager at Wright-Patterson, said in a statement.

Financial terms of the licensing agreement were not provided.


Evotec and Genedata to Co-Market Lead Discovery Instruments, Software

Evotec Technologies and Genedata said last week that they will co-market their screening instrumentation and drug-discovery software.

Under the agreement, the partners will jointly offer Evotec's Evoscreen and Plate Explorer high-throughput screening instruments and Acapella data-analysis software with Genedata's Screener validation software.


NCI's caBIG to Use DE-ID De-identification Software

DE-ID Data said last week that the National Cancer Institute has licensed its DE-ID software to be used as a de-identification component for the Tissue Banks and Pathology Workspace of the Cancer Biomedical Informatics Grid.

The NCI will use DE-ID internally and sublicense the software to sixteen NCI-designated cancer centers participating in caBIG.

The NCI license is for one year with the option to renew. Additional financial terms were not disclosed.

DE-ID was developed at the University of Pittsburgh Medical Center, where it is used as the de-identification software for all clinical research approved by the UPMC Institutional Review Board. DE-ID eliminates patient identifiers while maintaining the usability of the data through name proxies and date offsets, the company said.


Carnegie Mellon, U of Pittsburgh to Offer Joint Doctorate in Computational Biology

The University of Pittsburgh and Carnegie Mellon University said last week that they are launching a joint doctoral program in computational biology.

The new program has already accepted a "small number" of students to begin in fall 2005 and spring 2006 and will accept its first full class in fall 2006. The program is expected to reach a "steady enrollment" of 50 students.

The program will include "roughly equal numbers of faculty and students participating from both campuses," said Mark Kamlet, provost and senior vice president of Carnegie Mellon.

Robert Murphy, professor of biological sciences and biomedical engineering at Carnegie Mellon, and Ivet Bahar, professor and chairman of the department of computational biology at the University of Pittsburgh School of Medicine, will serve as co-directors of the PhD program.

Carnegie Mellon has offered a formal undergraduate degree program in computational biology since 1987 and began offering a master's degree in the field in 1999.

The University of Pittsburgh School of Medicine established its department of computational biology last year.

Filed under

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.